Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 13, 2001

View Archived Issues

SOD mimetic protects cardiac allografts from ischemia-reperfusion injury

Phase I findings support advancement of CI-1023 to phase II evaluation

Lipophilic metal chelator representative of new class of therapies for neurodegenerative disorders

WAY-812: a potent, long-acting 5-HT1A antagonist identified at Wyeth-Ayerst

Novel antidementia drug FK-960 more effective than and synergistic with donepezil

New formulation of tamoxifen may treat resistant breast cancers

FDA approves labeling change for Rhinocort Aqua

In vitro and in vivo studies show no lung deposition associated with Oralin

NPS receives milestone payment for potential schizophrenia treatment

LJP-1082 enters phase I/II clinical trial for antibody-mediated thrombosis

Na+ channel blocker as potential therapy for Parkinson's disease

AC-90222 exerts beneficial cognitive and antipsychotic effects in mice

PDT incorporating MV-0611 highlighted at AHA meeting as novel therapy for restenosis

Presentation of novel lipid-lowering and HDL-increasing PPAR activator at AHA

Gap junctions as a novel target for preventing ischemic reentry ventricular tachycardia

Factor Xa inhibition by CI-1031 prevents the formation of and deaggregates thrombi in pig model

Blockade of TP receptors by S-18886 prevents atherogenesis associated with diabetes

Adjunctive AR-C69931 with thrombolysis proves beneficial in canine thrombosis model

AeroDose albuterol inhaler compares favorably to other inhalation devices

Novel protein with potential in renal diseases discovered in Japan

Synthesis and biological evaluation of new CRF1 receptor antagonists

Banyu discloses new imidazolines active as NPY antagonists and uses of the same

Novel therapies for dementia and related disorders under study at Elan

Inhibitors of vascular smooth muscle cell proliferation patented by Taisho

Patent coverage obtained by Ono for new EP4 receptor antagonists

Naturally produced antibacterial compound reported by Kitasato Institute

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...